SCHEMBL21664129

SCHEMBL21664129

c1cc(C2=NCCS2)nc(-c2csc(-c3cscn3)n2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.35
IDO1 P14902 3/20 0.32
KDM4E B2RXH2 2/20 0.32
RAB9A P51151 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
GFER P55789 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 2/20 0.30
HDAC6 Q9UBN7 2/20 0.30
NPC1 O15118 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
CYP2D6 P10635 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21664015 0.94 IDO1 (0.32) CYP19A1IDO1KDM4ERAB9AALDH1A1
SCHEMBL21663821 0.89 SMN1; SMN2 (0.35) IDO1KDM4ERAB9AALDH1A1MAPT
SCHEMBL21664133 0.88 HDAC3 (0.34) IDO1HDAC6HDAC3HDAC1
SCHEMBL21664082 0.86 HDAC3 (0.33) IDO1HDAC6HDAC3HDAC1
SCHEMBL21663828 0.86 HDAC3 (0.33) IDO1HDAC6HDAC3HDAC1
SCHEMBL21663827 0.78 IDO1 (0.44) CYP19A1IDO1KDM4ERAB9AALDH1A1
SCHEMBL15842578 0.77 NOS3 (0.37) IDO1KDM4ERAB9AALDH1A1MAPT
SCHEMBL21663826 0.77
SCHEMBL21664204 0.77 CYP19A1 (0.38) CYP19A1KDM4ERAB9AALDH1A1MAPT
SCHEMBL21663829 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319347-B2 Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound FUJIFILM CORPORATION (JP) 2022-05-03 US disclosed
US-20200040039-A1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND FUJIFILM CORPORATION (JP) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200040039-A1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND VIP, NPPA, NGLY1 CYP19A1 2982/4885IDO1 4686/4885KDM4E 4736/4885
US-11319347-B2 Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound VIP, NPPA, NGLY1 CYP19A1 2982/4885IDO1 4686/4885KDM4E 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.